CACNA1A and aceruloplasminemia: Studies in transgenic mouse models with human pathogenic FHM mutations (Ferrari et al., 2015) have highlighted specific genetic and neurobiological mechanisms that can explain the spectrum of clinical symptoms, such as the aura and the cerebellar ataxia seen with specific mutations, suggesting that FHM may also be an attractive condition to understanding better the contribution of the cytokines in migraine.